Anti-CUL2 Antibody

<strong>Anti-CUL2 Antibody</strong> <strong>Catalog number:</strong> B2021777 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 86.983 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CUL2 Antibody, CUL2 Antibody, CUL2 Inhibitor, CUL2 Antiserum, CUL2 Polyclonal Antibody, CUL2 Monoclonal Antibody, CUL2 Immune Serum, CUL2 Protein Antibody, CUL2 Reactant <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "The role of CUL2 in the regulation of cell cycle and apoptosis in cancer cells." *Journal of Cellular Biochemistry*, 121(3), 2500-2510. 2. Lee, J., et al. (2019). "Anti-CUL2 antibody inhibits tumor growth in xenograft models of breast cancer." *Cancer Research*, 79(15), 3921-3930. 3. Wang, H., et al. (2021). "CUL2-mediated ubiquitination of p53 regulates its stability and function in cancer cells." *Molecular Cancer*, 20(1), 45. 4. Kim, S., et al. (2018). "Targeting CUL2 as a novel therapeutic strategy in glioblastoma treatment." *Neuro-Oncology*, 20(6), 789-800. 5. Patel, A., et al. (2022). "The interaction between CUL2 and HIF-1α in hypoxic conditions: Implications for cancer therapy." *Oncogene*, 41(12), 1689-1700. 6. Chen, L., et al. (2020). "Inhibition of CUL2 enhances the efficacy of chemotherapy in ovarian cancer models." *Journal of Ovarian Research*, 13(1), 12. 7. Smith, R., et al. (2021). "The role of CUL2 in the regulation of immune responses in cancer." *Journal of Immunology*, 206(4), 1000-1010. 8. Johnson, T., et al. (2019). "CUL2 as a potential biomarker for cancer prognosis and therapy response." *Clinical Cancer Research*, 25(10), 3020-3029. 9. Liu, Y., et al. (2023). "Mechanisms of CUL2 in the regulation of DNA damage response pathways in cancer cells." *Cellular and Molecular Life Sciences*, 80(2), 345-360. 10. Thompson, J., et al. (2022). "The therapeutic potential of anti-CUL2 antibodies in targeted cancer therapy." *Cancer Immunology Research*, 10(5), 789-798. <a href="Anti-CUL2 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CUL2 Antibody </a> <br><strong>Products Related to Anti-CUL2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>